User profiles for Adam Wheatley

Adam Wheatley

University of Melbourne
Verified email at unimelb.edu.au
Cited by 13131

[HTML][HTML] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

…, D Cromer, A Reynaldi, TE Schlub, AK Wheatley… - Nature medicine, 2021 - nature.com
Predictive models of immune protection from COVID-19 are urgently needed to identify
correlates of protection to assist in the future deployment of vaccines. To address this, we …

[HTML][HTML] Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

…, K Subbarao, MP Davenport, SJ Kent, AK Wheatley - Nature medicine, 2020 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …

[HTML][HTML] Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses

MG Joyce, AK Wheatley, PV Thomas, GY Chuang… - Cell, 2016 - cell.com
Antibodies capable of neutralizing divergent influenza A viruses could form the basis of a
universal vaccine. Here, from subjects enrolled in an H5N1 DNA/MIV-prime-boost influenza …

[HTML][HTML] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

AK Wheatley, JA Juno, JJ Wang, KJ Selva… - Nature …, 2021 - nature.com
The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …

Defining B cell immunodominance to viruses

…, HD Hickman, GM Frank, SR Das, AK Wheatley… - Nature …, 2017 - nature.com
Immunodominance (ID) defines the hierarchical immune response to competing antigens in
complex immunogens. Little is known regarding B cell and antibody ID despite its …

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

…, SF Andrews, HM Yassine, AK Wheatley… - Nature …, 2019 - nature.com
The present vaccine against influenza virus has the inevitable risk of antigenic discordance
between the vaccine and the circulating strains, which diminishes vaccine efficacy. This …

[HTML][HTML] Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

WS Lee, AK Wheatley, SJ Kent, BJ DeKosky - Nature microbiology, 2020 - nature.com
Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data …

[HTML][HTML] Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

…, A Reynaldi, JA Juno, AK Wheatley… - Nature Reviews …, 2022 - nature.com
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement. …

[HTML][HTML] Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis

…, M Steain, A Reynaldi, TE Schlub, AK Wheatley… - The Lancet …, 2022 - thelancet.com
Background Several SARS-CoV-2 variants of concern have been identified that partly escape
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …

[HTML][HTML] Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

…, JA Juno, D Khoury, A Reynaldi, AK Wheatley… - Nature Reviews …, 2021 - nature.com
Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is
central to long-term control of the current pandemic. Despite our rapidly advancing knowledge …